Company Profile
InMed Stock Price, News & Analysis
- Ticker:
- INM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Canada and listed in the U
Stock performance
1.43 USD (+2.14%)
Close
Last updated: August 6, 2026
5.04M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, INM closed up 2.14% at $1.43. No new same-company headline was identified in the current news window.
Company overview
Business overview
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications. Its story is centered on whether cannabinoid science can be translated into differentiated medicines.
Geographic Base and Sector Classification
InMed is headquartered in Canada and listed in the U.S. market. It sits in small-cap biotechnology with a cannabinoid focus.
Business Model Characteristics
The company depends on clinical and preclinical validation, regulatory clarity, and capital efficiency. Investors usually watch early data, platform direction, and whether the company can sharpen its therapeutic thesis.
Position Within the Biotechnology Landscape
InMed occupies a niche cannabinoid biotech position. The stock is catalyst-sensitive because the company must prove both scientific and commercial relevance.
Future catalysts
InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path. The market will care about human proof.
Recent news
- 01
- 02
InMed Submits Form 12b-25
Source: InMed
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of InMed (INM)?
InMed (INM) most recently closed at 1.43 USD, a +2.14% move versus the previous session.
What is the market cap of InMed (INM)?
InMed currently has a market capitalization of 5.04M USD on BioPharmSignal.
What does InMed do?
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications. Its story is centered on whether cannabinoid science can be translated into differentiated medicines.
On which exchange is INM stock listed?
InMed (INM) is associated with NASDAQ, Canada and listed in the U, Biopharma.
What is InMed?
InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path.
Which conditions is InMed targeting with InMed?
InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path.
How does InMed describe recent progress with InMed?
InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path.
What is Pharmaceuticals?
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications.